Radioiodine treatment after surgery for differentiated thyroid cancer: a reasonable option

Affiliations

¹ Department of Nuclear Medicine, Cochin University Hospital, Paris 5 René Descartes University, Paris, France.
² Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany.
³ Nuclear Medicine/Radiology, University of Michigan, Ann Arbor, USA.
⁴ Department of Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
⁵ Nuclear Medicine, Haut-Lévêque University Hospital, Bordeaux, France.
⁶ Department of Nuclear Medicine, European Center for Research in Medical Imaging, La Timone University Hospital, Aix-Marseille University, 264 rue Saint-Pierre, 13385, Marseille, France. david.taieb@ap-hm.fr.

Editorial

Jérôme Clerc et al. Eur J Nucl Med Mol Imaging. 2017 Jun.

. 2017 Jun;44(6):918-925.

doi: 10.1007/s00259-017-3654-z.

¹ Department of Nuclear Medicine, Cochin University Hospital, Paris 5 René Descartes University, Paris, France.
² Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany.
³ Nuclear Medicine/Radiology, University of Michigan, Ann Arbor, USA.
⁴ Department of Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
⁵ Nuclear Medicine, Haut-Lévêque University Hospital, Bordeaux, France.
⁶ Department of Nuclear Medicine, European Center for Research in Medical Imaging, La Timone University Hospital, Aix-Marseille University, 264 rue Saint-Pierre, 13385, Marseille, France. david.taieb@ap-hm.fr.

No abstract available

References